U.S. Other Utilities Stock News

Appian announced that David Link, Co-Founder and CEO of ScienceLogic, will join its Board of Directors and Audit Committee effective January 25, 2026, bringing expertise in AI-driven IT operations, observability, and automation. His background in applying AI and automation to complex, globally distributed systems offers Appian board-level insight directly aligned with its AI-powered process automation focus. Next, we assess how this board appointment, particularly Link’s AI and automation...

CVB Financial (CVBF) just wrapped up FY 2025 with fourth quarter revenue of US$136.4 million and basic EPS of US$0.41, alongside quarterly net income of US$55.0 million. Over the last few quarters, the company has seen revenue move from US$126.8 million in Q4 2024 to US$136.4 million in Q4 2025, while quarterly EPS ranged from US$0.36 to US$0.41 over the same period. With a trailing twelve month net income of US$209.3 million and EPS of US$1.53, the latest release keeps the focus firmly on...

What Shake Shack’s Recent Performance Signals for Investors Shake Shack (SHAK) has been on investors’ radar after a mixed run in the stock, with a small gain over the past month but a double digit decline over the past year catching attention. See our latest analysis for Shake Shack. At a share price of $92.59, Shake Shack’s recent performance has been mixed, with a 30 day share price return of 8.99% contrasting with a 1 year total shareholder return decline of 23.66%, suggesting short term...

Why Kyndryl Holdings (KD) is on investors’ radar now Kyndryl Holdings (KD) is back in focus after recent trading left the stock with a 1 day gain but negative moves over the week, month and past 3 months, prompting closer attention to its valuation and fundamentals. See our latest analysis for Kyndryl Holdings. At a share price of $24.88, Kyndryl’s 1 day share price return of 1.18% comes after weaker recent momentum, with a 30 day share price return of 8.29% decline and a 1 year total...

Summit Therapeutics has entered into a clinical trial collaboration with GSK to test ivonescimab alongside GSK’s B7-H3-targeting ADC in multiple solid tumors, while also submitting a Biologics License Application to the FDA for ivonescimab plus chemotherapy in EGFR-mutated non-small cell lung cancer. Together, these steps highlight ivonescimab as the central asset in Summit’s pipeline, moving simultaneously toward potential US approval and broader oncology combinations with a major...

Why Whirlpool Stock Is On Investors’ Radar Today Whirlpool (WHR) has caught investor attention after a strong recent share performance, with the stock up about 25% over the past month and about 22% in the past 3 months. See our latest analysis for Whirlpool. That sharp 30 day share price return of 25.24% and 90 day gain of 21.72% comes after a tougher stretch. The 1 year total shareholder return is still down 28.28%, so recent momentum is building off a lower base. If Whirlpool’s rebound has...

Recent trading in Shift4 Payments (FOUR) is being shaped by mixed analyst sentiment around its expansion plans, the ongoing integration of the Global Blue acquisition, and management’s confidence in reaching a sizeable free cash flow run rate. See our latest analysis for Shift4 Payments. At a share price of US$66.00, Shift4’s 1-day share price return of 3.12% and 30-day share price return of 1.88% sit against a weaker 90-day share price return of 13.45% and a 1-year total shareholder return...

Robert Half (RHI) shares moved after markets responded positively to the U.S. decision to pause new tariffs on European partners, with easing trade war concerns supporting a broader recovery in staffing and professional services stocks. See our latest analysis for Robert Half. At a share price of $28.66, Robert Half has seen a 1-day share price return of 1.96% and a 30-day share price return of 5.10%, yet its 1-year total shareholder return of 56.83% and 3-year total shareholder return of...

If you are wondering whether Brinker International at US$162.44 still offers value after a strong run, this article will walk through what the current price might imply. The stock has seen a 2.6% decline over the last 7 days, a 9.2% gain over 30 days, 7.2% year to date, 5.1% over 1 year, and a very large 3 year return that is a bit more than 3x, with a 5 year return of 171.4%. Recent attention on Brinker International has focused on how its brand positioning and store level performance tie...

If you are wondering whether Arcutis Biotherapeutics at US$26.65 is pricing in too much optimism or still leaving room on the table, the starting point is understanding what the market might already be expecting. The share price return sits at 1.1% over the last 7 days, with a 9.1% decline over 30 days, an 8.1% decline year to date, but a 96.0% return over 1 year and 65.5% over 3 years, which suggests sentiment around risk and potential has shifted over different time frames. Recent...

If you are wondering whether PulteGroup is still fairly priced after its big run over recent years, this article walks through what the current share price might be implying about value. The stock trades at US$127.77, with returns of 8.9% over the last 30 days, 7.3% year to date, 10.5% over 1 year, 149.8% over 3 years, and 201.0% over 5 years. This naturally raises questions about how much future upside or risk is already reflected in the price. Recent coverage has focused on PulteGroup as a...

MGM Resorts International (MGM) has reached a key sustainability milestone, now able to cover up to 100% of its daytime Las Vegas Strip electricity needs with solar power, supported by the Escape Solar and Storage Project. See our latest analysis for MGM Resorts International. Despite the clean energy milestone, MGM Resorts International’s recent share price performance has been mixed. A 1-day share price return of 1.53% contrasts with a weaker 30-day return of 6.90% and a modest 4.91% 90-day...

If you are wondering whether PDD Holdings is attractively priced right now, its recent share performance and valuation checks give you plenty to think about. The stock last closed at US$106.02, with returns of a 0.7% decline over 7 days, a 6.5% decline over 30 days, an 8.4% decline year to date, a 4.8% decline over 1 year, a 1.3% decline over 3 years, and a 36.0% decline over 5 years. These figures may influence how you think about its potential and risk today. Recent coverage around PDD...

Omnicell (NasdaqGS:OMCL) is highlighting its role in digital healthcare with a focus on medication management technology. The company has launched its XT Amplify program, aimed at expanding the reach and impact of its automated medication management offerings. The XT Amplify program is gaining traction in the market as healthcare providers look for more robust digital tools. For investors watching digital healthcare, Omnicell sits at the intersection of software, automation, and hospital...

Rumble stock at a glance Rumble (RUM) has drawn investor attention after a mixed run in recent periods, with a 1 day gain of 1.9% and a 7 day gain of 4.5% contrasting with weaker month and past 3 months returns. See our latest analysis for Rumble. Rumble’s recent 1 day and 7 day share price gains sit against weaker 1 month and 3 month share price returns and a 1 year total shareholder return decline of 51.39%, suggesting momentum has been fading over a longer stretch. If Rumble’s moves have...

Southwest Airlines plans to introduce assigned seating and premium cabins starting January 27, 2026. The company will add new hub cities and redeye flights while keeping its policy of two free checked bags. Leadership changes and input from activist investors are influencing a broad shift in how Southwest positions itself against legacy carriers. For investors watching NYSE:LUV, these changes come as the stock trades at $42.44, with a 1 year return of 35.8% and a 3 year return of 27.1%. The...

Limbach Holdings (LMB) shares are in focus after the company named longtime executives Nick Angerosa and Jay Sharp to new leadership roles overseeing national customer solutions and sales. See our latest analysis for Limbach Holdings. The latest leadership appointments come as Limbach’s share price trades at US$86.81, with a 7.52% 1 month share price return and a 9.79% year to date share price return. This contrasts with a 17.58% 1 year total shareholder return decline and a very large 3 year...

Chord Energy (NasdaqGS:CHRD) has completed the acquisition of Enerplus, expanding its position in the Williston Basin. The deal adds to Chord Energy's inventory and is expected to improve its capital efficiency profile. This combination creates a larger, more concentrated Williston-focused operator with greater operational scale. Chord Energy, trading at $94.85, now reflects a business that is meaningfully larger in the Williston Basin through the Enerplus acquisition. The stock is up 3.2%...

Atlantic International Corp. ( NASDAQ:ATLN ) shareholders would be excited to see that the share price has had a great...

Suburban Propane Partners, L.P. recently promoted M. Douglas Dagan to the newly created role of Senior Vice President – Renewable Energy, tasking him with leading the strategic growth and operations of its Suburban Renewable Energy, LLC platform. By elevating renewable energy leadership to the senior executive level, the partnership is signaling a more formalized commitment to expanding beyond its traditional propane-focused operations. We’ll now examine how this renewed executive focus on...

If you are wondering whether CDW is starting to look interesting on price, this article walks through what the current share level might be implying about value. CDW last closed at US$129.31, with returns of a 2.3% decline over 7 days, a 6.4% decline over 30 days and a 2.9% decline year to date, while the 1 year return sits at a 33.5% decline. Recent share price moves are drawing attention back to how the market is currently viewing IT services and solutions providers like CDW. With a 30 day...

Old National Bancorp (ONB) has drawn fresh attention after reporting record adjusted earnings per share, net income, and efficiency ratio, along with solid core deposit and loan growth and a completed Bremer Bank integration. See our latest analysis for Old National Bancorp. That earnings release and the completed Bremer integration have coincided with clear momentum in the stock, with a 90 day share price return of 15.15% and a 5 year total shareholder return of 64.74%. This points to...

Recent commentary highlighted DRDGOLD Ltd’s strong earnings momentum, high return on equity and minimal debt, alongside technical strength with shares trading near their 52-week high. With a very high relative strength score and relatively low institutional ownership, the stock is drawing attention as a potential CAN SLIM candidate among growth-oriented investors. We’ll now examine how this combination of robust earnings momentum and balance-sheet strength influences DRDGOLD’s broader...

In January 2026, Insight Enterprises reported a softer quarter with a 4% year-on-year revenue decline and results that missed analysts' revenue and earnings estimates, even as the IT Distribution & Solutions sector faced mixed conditions. Around the same time, Insight announced an expanded global partnership with Stripe to help large enterprises modernise legacy financial infrastructure and enable AI-driven commerce experiences, including purchases directly within platforms like ChatGPT via...